Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in IVVD — Invivyd, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to IVVD Full portfolio

Position in IVVD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$153,930
+$153,605 QoQ
Shares Held
176,526
+70510.4% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 124 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IVVD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. IVVD ranks #271 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in IVVD

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $153,930 176,526
2026-03-31 $325 250
2025-12-31 $617 250
2025-09-30 $275 250
2025-06-30 $1,457 2,040
2025-03-31 $28,950 47,852
2024-12-31 $20,731 46,799
2024-09-30 $37,394 36,661
2024-06-30 $38,605 35,096
2024-03-31 $3,019 680
2023-12-31 $2,655 674
2023-09-30 $1,506 886
2023-06-30 $915 872
2023-03-31 $11,575 9,646
2022-12-31 $1,132 755
2022-09-30 $2,823 902
2022-06-30 $4,056 1,237
2022-03-31 $92,098 20,197
2021-12-31 $140,262 19,320
2021-09-30 $4,561 108